2024

1. Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA

   Annals of Oncology, Vol. 35, Núm. 9, pp. 805-816

2. Characteristics of women with type 2 diabetes mellitus and heart failure in Spain. The DIABET-IC study

   Cardiology Journal, Vol. 31, Núm. 1, pp. 103-110

3. Combined Treatment Scenarios for Patients With Severe Asthma and Chronic Rhinosinusitis With Nasal Polyps. A Proposal From GEMA-POLINA Task Force

   Open Respiratory Archives, Vol. 6, Núm. 3

4. Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients

   Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 23-32

5. Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatment

   Journal of Psychopharmacology

6. Exercise in cancer patients: assistance levels and referral pathways—a position statement from the Spanish Society of Medical Oncology

   Clinical and Translational Oncology

7. Exposome and basal cell carcinoma: a multicenter case–control study

   International Journal of Dermatology, Vol. 63, Núm. 7, pp. 907-915

8. Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study

   American Journal of Kidney Diseases

9. Global Lung Initiative as Diagnostic Criteria in Asthma-COPD Overlap Syndrome: Prevalence and Disease Characterization in a Real-Life Asthma Cohort

   Journal of investigational allergology & clinical immunology, Vol. 34, Núm. 3, pp. 192-195

10. Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register

    RMD open, Vol. 10, Núm. 1

11. Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study

    Alimentary Pharmacology and Therapeutics

12. Low penetrance of frequent ATP7B mutations explains the low prevalence of Wilson disease. Lessons from real-life registries.

    Digestive and Liver Disease

13. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

14. PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention

    Lipids in Health and Disease , Vol. 23, Núm. 1

15. Penetrance of Dilated Cardiomyopathy in Genotype-Positive Relatives

    Journal of the American College of Cardiology, Vol. 83, Núm. 17, pp. 1640-1651

16. Phenotype and Clinical Outcomes in Desmin-Related Arrhythmogenic Cardiomyopathy

    JACC: Clinical Electrophysiology, Vol. 10, Núm. 6, pp. 1178-1190

17. Predictors of outcomes after internal fixation of periprosthetic femoral hip fractures Subgroup analysis of the peri-implant and peri-prosthetic fractures Spanish registry (PIPPAS)

    Injury, Vol. 55, Núm. 10

18. Prevalence and incidence of heart failure in type 2 diabetes patients: results from a nationwide prospective cohort—the DIABET-IC study

    Cardiovascular Diabetology, Vol. 23, Núm. 1

19. Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury

    Spinal Cord, Vol. 62, Núm. 8, pp. 454-467

20. Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

    European Journal of Clinical Investigation